Stay updated on VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has been updated to reflect a new suspension status and pending amendments, with new dates for 2025 added, while previous contact information and dates from 2024 have been removed.SummaryDifference1%
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has added a new contact for cancer clinical trials, Ardaman Shergill, MD, along with a revision update to v2.14.0, while removing the previous type of intervention from v2.13.3.SummaryDifference0.3%
Stay in the know with updates to VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.